Please use this identifier to cite or link to this item:

TitleMetformin-like effect of salvia officinalis (common sage) : is it useful in diabetes prevention?
Author(s)Lima, Cristóvão F.
Azevedo, Marisa
Araújo, Rita
Ferreira, Manuel Fernandes
Wilson, Cristina Pereira
KeywordsSalvia officinalis L.
Rat hepatocyte
Hypoglycaemic effects
Diabetes: Metformin
Issue dateAug-2006
PublisherCambridge University Press
JournalBritish Journal of Nutrition
Citation"British journal of nutrition". ISSN 1475-2662. 96:2 (Aug. 2006) 326-333.
Abstract(s)Common sage (Salvia officinalis L) is among the plants that are claimed to be beneficial to diabetic patients, and previous studies have suggested that some of its extracts have hypoglycaemic effects in normal and diabetic animals. In this study we purposed to verify the antidiabetic effects of the most common form of consumption of this plant as an infusion (tea). Replacing water with sage tea for 14 days lowered fasting plasma glucose in normal mice but had no effect on glucose clearance in response to an intraperitoneal glucose tolerance test. This indicated effects at level of the liver on gluconeogenesis. Hepatocyte primary cultures of healthy sage tea drinking rats showed, after stimulation, high glucose uptake capacity and a decreased gluconeogenesis in response to glucagon. Sage essential oil further increased hepatocyte sensitivity to insulin and inhibited gluconeogenesis. Overall these effects resemble those of the pharmaceutical drug metformin, a known inhibitor of gluconeogenesis used in the treatment and prevention of type 2 diabetes mellitus. In primary cultures of rat hepatocytes isolated from streptozotocin-induced diabetic rats none of these activities were observed. These results seem to indicate that sage tea does not possess antidiabetic effects at this level. However, its effects on fasting glucose levels in normal animals and the metformin-like effects on rat hepatocytes suggest that sage may be useful as food supplement in the prevention of type 2 diabetes mellitus by lowering plasma glucose of individuals at risk.
Publisher version 14/nw=1/rpsv/cgi-bin/linker?ini=cabi&reqidx= /ij/cabi/00071145/v96n2/s15/p326
AccessOpen access
Appears in Collections:DBio - Artigos/Papers

Files in This Item:
File Description SizeFormat 
BJN_96_2__326.pdf147,08 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID